World Politics

Coronavirus Live Updates: As India Imposes 21-Day Lockdown, Trump Calls for U.S. to Be Open ‘by Easter’

States including California, Maryland, Illinois and Washington have declared stay-at-home or shutdown orders, but other states have been looking for directives from the Trump administration. And countries in Asia are beginning to see a resurgence of coronavirus after easing up on restrictions.

For governors and mayors who have been trying to educate people about the urgent need to stay home and maintain social distance, Mr. Trump’s recent statements suggesting that such measures may be going too far threatened to make their jobs more difficult.

“Some of the messaging is pretty confusing,” Gov. Larry Hogan of Maryland, a Republican who moved this week to close nonessential businesses in his state, said in an interview Tuesday morning on CNN, before the president announced his new Easter goal, when he was asked about the Mr. Trump’s talk in recent days of relaxing social distancing guidelines. “I think it’s not just it doesn’t match with what we’re doing here in Maryland. Some of the messaging coming out of the administration doesn’t match.”

Mr. Hogan, the chairman of the bipartisan National Governors Association, said that health officials suggest that the virus’s peak could be weeks or months away. “We’re just trying to take the best advice that we can from the scientists and all the experts, and making the decisions that we believe are necessary for our states,” he said.

But the president and vice president were resolute that they want the country reopened. Mr. Pence said the administration’s timeline for trying to get businesses restarted and workers out of their homes was shorter than the period that health experts have said would be necessary to flatten the curve.

“We’ll focus on our most vulnerable, but putting America back to work will also be a priority, in weeks not months,” Mr. Pence said.

He also said two malaria drugs, chloroquine and hydroxychloroquine, have been approved by the Food and Drug Administration for off-label use treating patients with Covid-19, the disease caused by the coronavirus. The F.D.A. did not immediately confirm that assertion, but two administration health officials said it was not true.

Source link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top